Richard W. Paul & Associates LLC Increases Position in iShares Biotechnology ETF (NASDAQ:IBB)

Richard W. Paul & Associates LLC raised its position in iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 1,326.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,264 shares of the financial services provider’s stock after purchasing an additional 4,895 shares during the quarter. Richard W. Paul & Associates LLC’s holdings in iShares Biotechnology ETF were worth $715,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in IBB. Activest Wealth Management purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth $58,000. Householder Group Estate & Retirement Specialist LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth $60,000. HB Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth $219,000. Column Capital Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth $49,000. Finally, Premier Path Wealth Partners LLC purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $207,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock traded down $0.13 on Wednesday, reaching $133.76. 769,195 shares of the stock were exchanged, compared to its average volume of 1,836,373. The business’s 50 day moving average price is $136.49 and its 200 day moving average price is $129.02. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were paid a $0.126 dividend. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a yield of 0.38%.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Stories

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.